We are live on
!
Find out more
GENE
Genetic Technologies Ltd.
GENE
GENE
Delisted
GENE was delisted on the 16th of October, 2024.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
1
Virtu KCG Holdings
New York
| $85K | +$63.5K | +397 | +187% |
|
2
Citadel Advisors
Miami,
Florida
| $65K | +$74.2K | +464 | New |
|
3
Morgan Stanley
New York
| $38K | +$43.4K | +271 | New |
|
|
ARTA
4
A.R.T. Advisors
New York
| $20K | +$23.8K | +149 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $18K | +$17.9K | +112 | +700% |
|
|
APU
6
Alpine Partners USVI
St. Thomas,
U.S. Virgin Islands
| $16K | – | – | – |
|
|
CIM
7
Calvert Investment Management
Bethesda,
Maryland
| $15K | +$17K | +106 | New |
|
|
U
8
UBS
Zurich,
Switzerland
| $14K | +$16K | +100 | New |
|
9
Group One Trading
Chicago,
Illinois
| $2K | +$1.76K | +11 | +275% |
|
10
Citigroup
New York
| $1K | +$320 | +2 | +67% |
|